Core Laboratories Inc

Core Laboratories Inc(CLB)股票分析

$12.360

+0.070 (+0.57%)收盤時

Loading chart…
High
12.430
Open
12.330
VWAP
12.35
Vol
268.01K
Mkt Cap
922.56M
Low
12.250
Amount
3.31M
EV/EBITDA, TTM
13.02

Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. It assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. Its segments include Reservoir Description, which provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry, and Production Enhancement segment, which provides integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects.

AI analysis of Core Laboratories Inc (CLB)

hold

Core Laboratories Inc is currently priced at $12.36, which is below the upgraded analyst target of $21, indicating potential upside. However, the recent downgrade by BofA to a target of $11 highlights a significant risk. The RSI is at 58.107, suggesting the stock is nearing overbought territory, and the 20-day price change is +16.17%, indicating recent positive momentum. The main risk is the potential for further declines, as indicated by the 5-day change of -1.28% and the overall YTD change of -27.08%.

Analyst Ratings (18)

-6.96% downside
Buy
10 Buy
8 Hold
0 Sell
Current: 12.36
最低
11.50
平均
11.50
最高
11.50

Johnson Rice

2026-08-13

目標價

$21

Buy

BofA

2026-07-15

目標價

$11

Underperform

Stifel

2025-07-16

目標價

$12

Hold

Citi

2025-05-13

目標價

$13

Neutral

Stifel

2025-04-25

目標價

$13

Hold

估值指標

The current forward P/E ratio for Core Laboratories Inc (CLB) is 19.76, compared to its 5-year average forward P/E of 23.59.

Forward P/E

Fair
5Y Average P/E
23.59
Current P/E
19.76
高估
31.92
低估
15.26

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
15.16
Current EV/EBITDA
13.02
高估
20.13
低估
10.19

Forward P/S

Undervalued
5Y Average P/S
1.71
Current P/S
1.05
高估
2.21
低估
1.21

Alphio AI Price Scenarios for CLB

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%CLB

$12.15

情境價格

B

Base

Base · 50%CLB

$11.83

情境價格

B

Bear

Bear · 25%CLB

$9.77

情境價格

Whales holding CLB

A

Ariel Investments, LLC

+ HoldingCLB

+3.35%

3M Return

C

CWA Asset Management Group, LLC

+ HoldingCLB

+2.03%

3M Return

事件時間軸

2026-07-29 (ET)

17:30:00

Sees Q3 Revenue of $128.5M-$135.5M

17:30:00

Core Lab Reports Q2 Revenue of $124.6M

2026-06-26 (ET)

17:30:00

S&P Global to Spin Off Mobility Global on July 1

2026-04-29 (ET)

17:00:00

Core Lab Q1 Revenue at $121.8M, Below Consensus

17:00:00

Sees Q2 Revenue of $123M-$131M

資訊

CLB FAQ — answered by Alphio AI

Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. It assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. Its segments include Reservoir Description, which provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry, and Production Enhancement segment, which provides integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects. It operates in the Industrials sector (OIL & GAS FIELD SERVICES, NEC industry).

Core Laboratories Inc is currently priced at $12.36, which is below the upgraded analyst target of $21, indicating potential upside. However, the recent downgrade by BofA to a target of $11 highlights a significant risk. The RSI is at 58.107, suggesting the stock is nearing overbought territory, and the 20-day price change is +16.17%, indicating recent positive momentum. The main risk is the potential for further declines, as indicated by the 5-day change of -1.28% and the overall YTD change of -27.08%.

18 analysts cover CLB: 10 rate it Buy, 8 Hold and 0 Sell. The average price target is 11.50.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始